Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 496 AL 510

Navigating the intersection: Diabetes and Alzheimer's intertwined relationship

Kale MB, Bhondge HM, Wankhede NL, Shende PV, Thanekaer RP, Aglawe MM, Rahangdale SR, Taksande BG, Pandit SB, Upaganlawar AB, Umekar MJ, Kopalli SR, Koppula S.

Ageing Res Rev. 2024 Sep;100:102415. doi: 10.1016/j.arr.2024.102415. Epub 2024 Jul 14.

Phytochemicals targeting mitophagy: Therapeutic opportunities and prospects for treating Alzheimer's disease

Yang J, Zhao H, Qu S.

Biomed Pharmacother. 2024 Aug;177:117144. doi: 10.1016/j.biopha.2024.117144. Epub 2024 Jul 14.

Comparative Analysis of Retinal Structural and Angiographic Parameters in Diabetic Patients, Alzheimer's Disease Patients, and Healthy Controls: An OCT-Based Study

Borodi PG, Slevin M, Hopulele-Petri A, Crainic A, Pop P, Gavriș IM, Gavriș MM.

Rom J Ophthalmol. 2024 Apr-Jun;68(2):143-147. doi: 10.22336/rjo.2024.26.

Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer's disease

Conn KA, Borsom EM, Cope EK.

Gut Microbes. 2024 Jan-Dec;16(1):2371950. doi: 10.1080/19490976.2024.2371950. Epub 2024 Jul 15.

An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer's disease

López-Cerdán A, Andreu Z, Hidalgo MR, Soler-Sáez I, de la Iglesia-Vayá M, Mikozami A, Guerini FR, García-García F.

Neurobiol Dis. 2024 Sep;199:106605. doi: 10.1016/j.nbd.2024.106605. Epub 2024 Jul 14.

Developing public-private R&D consortia to accelerate Alzheimer's disease drug development

West J, Olk P.

Drug Discov Today. 2024 Sep;29(9):104103. doi: 10.1016/j.drudis.2024.104103. Epub 2024 Jul 15.

The duality of amyloid-β: its role in normal and Alzheimer's disease states

Azargoonjahromi A.

Mol Brain. 2024 Jul 17;17(1):44. doi: 10.1186/s13041-024-01118-1.

Drugs targeting APOE4 that regulate beta-amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease

Poblano J, Castillo-Tobías I, Berlanga L, Tamayo-Ordoñez MC, Del Carmen Rodríguez-Salazar M, Silva-Belmares SY, Aguayo-Morales H, Cobos-Puc LE.

Basic Clin Pharmacol Toxicol. 2024 Sep;135(3):237-249. doi: 10.1111/bcpt.14055. Epub 2024 Jul 17.

The reciprocal relationship between amyloid precursor protein and mitochondrial function

Strope TA, Wilkins HM.

J Neurochem. 2024 Sep;168(9):2275-2284. doi: 10.1111/jnc.16183. Epub 2024 Jul 18.

Drive My CAR-AD Research here, there and Everywhere

Sáez JMG.

Curr Alzheimer Res. 2024;21(1):1-2. doi: 10.2174/156720502101240524145811.

Genome-wide meta-analysis identifies ancestry-specific loci for Alzheimer's disease

Ge YJ, Chen SD, Wu BS, Zhang YR, Wang J, He XY, Liu WS, Chen YL, Ou YN, Shen XN, Huang YY, Gan YH, Yang L, Ma LZ, Ma YH, Chen KL, Chen SF, Cui M, Tan L, Dong Q, Zhao QH, Wang YJ, Jia JP, Yu JT.

Alzheimers Dement. 2024 Sep;20(9):6243-6256. doi: 10.1002/alz.14121. Epub 2024 Jul 18.

[Comparaison du déclin fonctionnel entre des patients atteints de démence à corps de Lewy et de la maladie d'Alzheimer]

Rouet A, Autieri V, Dieudonné B, Greffard S, Barrou Z, Tomeo C, Haddad R, Cohen-Bittan J, Boddaert J, Genet B, Verny M.

Geriatr Psychol Neuropsychiatr Vieil. 2024 Jun 1;22(2):241-253. doi: 10.1684/pnv.2024.1177.

Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer's diseases therapy

Soltan OM, Abdelrahman KS, Bass AKA, Takizawa K, Narumi A, Konno H.

Bioorg Chem. 2024 Oct;151:107651. doi: 10.1016/j.bioorg.2024.107651. Epub 2024 Jul 15.

Cannabidiol and Alzheimer's disease

Marques BL, Campos AC.

Int Rev Neurobiol. 2024;177:121-134. doi: 10.1016/bs.irn.2024.04.014. Epub 2024 Jul 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias